Comet Bio, a Canadian manufacturer of healthy and sustainable ingredients, completed the company’s Series C with an initial close of $22M. The round was led by Open Prairie, a multi-faceted private equity fund management firm with headquarters in Effingham, Illinois. Other investors include Louis Dreyfus Company (LDC), BDC Capital, and existing investor Sofinnova Partners.
“Thanks to the support of our exceptional investors, we will now be able to invest in a dedicated manufacturing facility to grow the supply of our upcycled ingredients,” said Rich Troyer, CEO of Comet Bio. “We will also be investing in innovation including our product pipeline and health claims development.”
Comet Biorefining, the Canadian company focused on the production of high-purity cellulosic dextrose, completed a round of equity financing led by new investor PM Equity Partner. Current investor Sofinnova Partners and new investor Bioindustrial Innovation Canada (BIC) also participated in the financing, whose terms were not disclosed.
IL BIOECONOMISTA 